NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDTocilizumab Tyenne ®
(COVID-19 ) 		Infections, Antiviral drugs, 05.03
REDTocilizumab Tyenne® Musculoskeletal and joint diseases, Cytokine modulators, 10.01.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Tocilizumab Tocilizumab Anti-Infective, Immunosuppressants, Interleukin Inhibitors
Viral Infection, Coronavirus
Tocilizumab Tocilizumab Immune System, Immunosuppressants, Interleukin Inhibitors
Immune System Disorders And Transplantation
Tocilizumab Tocilizumab Musculoskeletal System, Immunosuppressants, Interleukin Inhibitors
Arthritis
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Medicine Request Form - Tocilizumab
NICE TA238: Arthritis (juvenile idiopathic, systemic) - tocilizumab
NICE TA247: Rheumatoid arthritis - tocilizumab (rapid review TA198)
NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
NICE TA375:Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis
NICE TA518: Tocilizumab for treating giant cell arteritis
NICE TA878: Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
Tocilizumab Prescription and Administration Form